<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We investigated the prevalence of various autoantibodies [anti-<z:chebi fb="0" ids="28494">cardiolipin</z:chebi> antibody (aCL), <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LA), immune complexes (ICs), anti-nuclear antibody (ANA), and anti-<z:chebi fb="9" ids="16991">deoxyribonucleic acid</z:chebi> antibody (aDNA)] in hemophiliac individuals with (n = 50) and without (n = 42) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> by human <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> virus type 1 (HIV-1) </plain></SENT>
<SENT sid="1" pm="."><plain>The positivity rate for ANA was similar in both groups, and none of the patients was positive for LA and aDNA </plain></SENT>
<SENT sid="2" pm="."><plain>aCL was positive in 35 of 50 (70%) HIV-1-positive hemophiliac individuals and 33 of 42 (79%) HIV-1-negative hemophiliac individuals </plain></SENT>
<SENT sid="3" pm="."><plain>However, the majority of the aCL was revealed to be beta 2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I independent, thus corresponding to a <z:e sem="disease" ids="C0039128" disease_type="Disease or Syndrome" abbrv="">syphilis</z:e> type aCL that does not cause the so-called <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>A total of 39 of the 45 HIV-1 positive hemophiliac individuals (87%) and 34 of 41 HIV-1-negative hemophiliac individuals (83%) had at least one type of IC [C1q-, C3d-, and/or murine monoclonal rheumatoid factor (mRF)- IgG] </plain></SENT>
<SENT sid="5" pm="."><plain>The mechanism producing various autoantibodies in hemophiliac persons irrespective of their HIV-1 status is still unclear, but pathogens (e.g., HIV-1, <z:hpo ids='HP_0012115'>hepatitis</z:hpo> B, and <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C) and alloantigens in the blood products that these patients require may be possible candidates </plain></SENT>
<SENT sid="6" pm="."><plain>The clinical significance of the presence of these autoantibodies and the underlying mechanisms involved both need to be clarified further </plain></SENT>
</text></document>